This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
The Captor Opportunity (B)
Valentí Vidal, Albert; González Rodríguez, Jorge; Reutskaja Pastushkova, Elena; Mendoza, ErnestCase M-1398-EMarketingCarbon Purity (CP) acquired Captor Materials S.L. (CM). The main asset of Captor Materials was a patented technology for the removal of nitrogen oxides (NOx). Accumulated exposure to NOx causes gradual health deterioration in employees exposed to these gases. The new Captor technology, which helps remove these NOx, is extremely valuable and can be implemented in a number of sectors where NOx are to be removed from gases. CP identified several mar...Starting at €5.74
-
The Captor Opportunity (A)
Valentí Vidal, Albert; González Rodríguez, Jorge; Reutskaja Pastushkova, Elena; Mendoza, ErnestCase M-1397-EMarketingCarbon Purity (CP) acquired Captor Materials S.L. (CM). The main asset of Captor Materials was a patented technology for the removal of nitrogen oxides (NOx). Accumulated exposure to NOx causes gradual health deterioration in employees exposed to these gases. The new Captor technology, which helps remove these NOx, is extremely valuable and can be implemented in a number of sectors where NOx are to be removed from gases. CP identified several mar...Starting at €8.20
-
The Captor Opportunity (C)
Valentí Vidal, Albert; González Rodríguez, Jorge; Reutskaja Pastushkova, Elena; Mendoza, ErnestCase M-1399-EMarketingCarbon Purity (CP) acquired Captor Materials S.L. (CM). The main asset of Captor Materials was a patented technology for the removal of nitrogen oxides (NOx). Accumulated exposure to NOx causes gradual health deterioration in employees exposed to these gases. The new Captor technology, which helps remove these NOx, is extremely valuable and can be implemented in a number of sectors where NOx are to be removed from gases. CP identified several mar...Starting at €5.74
-
Harvard Business School's Sandra J. Sucher on the value of a book club for excutives (Spanish version)
Sucher, Sandra J.; Peebles, M. EllenArticle HBS-F0801FLeadership and People ManagementWhen executives meet together to grapple with moral and ethical questions in literature, they end up applying their insights in practice. This Harvard Business School professor endorses book clubs as part of leadership development. To view a list of recommended texts for an executive book club, visit sucher.readings.hbr.orgStarting at €8.20
-
Harvard Business School's Sandra J. Sucher on the value of a book club for excutives
Sucher, Sandra J.; Peebles, M. EllenArticle HBS-F0801F-ELeadership and People ManagementWhen executives meet together to grapple with moral and ethical questions in literature, they end up applying their insights in practice. This Harvard Business School professor endorses book clubs as part of leadership development. To view a list of recommended texts for an executive book club, visit sucher.readings.hbr.orgStarting at €8.20
-
And Now, a Word from Our Sponsor (HBR Case Study and Commentary) (Spanish version)
Gamgort, Bob; Nelson, Michelle R.; Thompson, Mozelle W.; Sheehan, Mike; Peebles, M. EllenArticle HBS-R0310AMarketingBryant Pharmaceutical's flagship product, a popular arthritis medicine called Seflex, is selling well--but not well enough. With generic versions due on the shelves in a couple of years, the drug company is looking for a dramatic sales increase. VP Laura Goldenberg knows she has to reach more consumers, but in an environment where people bombarded with advertising are using devices such as TiVo to skip ads, her job has suddenly taken on a new int...Starting at €8.20
-
And Now, a Word from Our Sponsor (HBR Case Study and Commentary)
Gamgort, Bob; Nelson, Michelle R.; Thompson, Mozelle W.; Sheehan, Mike; Peebles, M. EllenArticle HBS-R0310A-EMarketingBryant Pharmaceutical's flagship product, a popular arthritis medicine called Seflex, is selling well--but not well enough. With generic versions due on the shelves in a couple of years, the drug company is looking for a dramatic sales increase. VP Laura Goldenberg knows she has to reach more consumers, but in an environment where people bombarded with advertising are using devices such as TiVo to skip ads, her job has suddenly taken on a new int...Starting at €8.20
-
Into the Fray (HBR Case Study and Commentary)
Peebles, M. Ellen; Widmann, Nancy Clifford; Kopelan, Amy Dorn; Hassan, Fred; Cohen, Allan; Rhodes, Gary B.Article HBS-R0501A-ELeadership and People ManagementTalk of cost cutting and layoffs was already in the air in the New York offices of international beverage company Legrand SA. But now everyone is imagining the worst after the sudden and mysterious resignation of Lucien Beaumont, the company's president of U.S. operations. The rumors are flying fast and furious about what prompted his departure and, just as important, who will get Lucien's job. Michael Feldstein is confident that he's a top conte...Starting at €8.20